Omega Hospitals is securing a $59.79 million funding to fund the growth
Indian oncology hospital chain Omega Hospitals has raised Rs5 billion ($59.79 million) from a fund managed by Morgan Stanley Personal Fairness Asia in its first personal fairness fundraising.
The Hindu reported that the funding in Omega Hospitals' mum or dad firm, the Hyderabad Institute of Oncology, will help the corporate's bold growth plans throughout a number of Indian states.
Omega Hospitals will use the funding to fund progress in Telangana, Andhra Pradesh, Karnataka, Maharashtra, Tamil Nadu, Madhya Pradesh and West Bengal.
Led by surgical oncologist and Managing Director Dr. Mohan Vamsy, Omega Hospitals is India's second largest cancer-focused hospital chain.
The corporate was based in 2010 and presently employs 5,000 folks, with a minimum of ten hospitals in several cities and a mixed capability of 1,400 beds.
It supplies 24/7 emergency care and has handled greater than 105,000 sufferers since its inception.
Acquire entry to essentially the most complete firm profiles available on the market, powered by GlobalData. Save hours of analysis. Acquire aggressive benefit.
Firm Profile – Free Pattern
Your obtain e mail will arrive shortly
We’ve got confidence within the distinctive high quality of our firm profiles. Nevertheless, we wish you to take advantage of helpful choice for your enterprise. That's why we give you a free pattern which you could obtain by submitting the shape under.
By GlobalData
The partnership with Morgan Stanley PE Asia goals to speed up Omega Hospitals' efforts to offer complete most cancers care companies throughout India, which has grow to be extra pressing because of the rising incidence of most cancers lately.
Dr. Vamsy stated the corporate is “excited” to become India's largest most cancers care chain within the coming years.
The corporate's progress technique consists of each natural growth and inorganic acquisitions.
Omega Hospitals President Haragovind stated: “The plan is to develop the enterprise by a mixture of natural growth and inorganic acquisitions throughout markets.
“The financing from Morgan Stanley will catalyze our progress plans and assist set up a management place in most cancers care.”
Morgan Stanley PE Asia MD and co-head Arjun Saigal stated: “From an Asia perspective, we see a big alternative within the Indian specialty hospital area.
“This can be our second funding in an Indian most cancers hospital chain in a span of 12 months.”
